Tivicay PD 5 MG Tablet for Oral Suspension

RxCUI: 2374566
RxNorm name: Tivicay PD 5 MG Tablet for Oral Suspension
Display name: Tivicay PD 5 MG Tablet for Oral Suspension
Full name: Tivicay PD 5 MG Tablet for Oral Suspension
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Tivicay	DOLUTEGRAVIR SODIUM	ViiV Healthcare Company	63df5af3-b8ac-4e76-9830-2dbb340af922	2025-10-29	Warnings, Adverse reactions	Exact identifier rxcui: 2374566

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set ID	RxNorm string	TTY	SPL version	Label	Effective
63df5af3-b8ac-4e76-9830-2dbb340af922	Tivicay PD 5 MG Tablet for Oral Suspension	SY	31	These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013	20251029
63df5af3-b8ac-4e76-9830-2dbb340af922	Tivicay PD 5 MG Tablet for Oral Suspension	PSN	31	These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013	20251029
63df5af3-b8ac-4e76-9830-2dbb340af922	dolutegravir 5 MG Tablet for Oral Suspension [Tivicay]	SBD	31	These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013	20251029
63df5af3-b8ac-4e76-9830-2dbb340af922	Tivicay PD 5 MG (as dolutegravir sodium) Tablet for Oral Suspension	SY	31	These highlights do not include all the information needed to use TIVICAY safely and effectively. See full prescribing information for TIVICAY. TIVICAY (dolutegravir) tablets, for oral use TIVICAY PD (dolutegravir) tablets for oral suspension Initial U.S. Approval: 2013	20251029